IP Library Granted Patent US 10,092,600
Granted Patent B2
US 10,092,600 · App. 15/388,428 · Granted Oct 9, 2018

Method of preparing an adipose tissue derived matrix

Inventors: Yen-Chen Huang (East Brunswick, NJ); Asia Ivery (Hammonds Plains, CA); Bryan Choi (San Marcos, CA); Benjamin Schilling (Pittsburgh, PA); Manh-Dan Ngo (Matawan, NJ)
Assignee: Musculoskeletal Transplant Foundation
A61K35/35A61L27/3604A61L27/3683A61L2430/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,092,600
App. No.
15/388,428
Granted
Oct 9, 2018
Kind
B2
Abstract

An acellular soft tissue-derived matrix includes a collagenous tissue that has been delipidated and decellularized. Adipose tissue is among the soft tissues suitable for manufacturing an acellular soft tissue-derived matrix. Exogenous tissuegenic cells and other biologically-active factors may be added to the acellular matrix. The acellular matrix may be provided as particles, a slurry, a paste, a gel, or in some other form. The acellular matrix may be provided as a three-dimensional scaffold that has been reconstituted from particles of the three-dimensional tissue. The three-dimensional scaffold may have the shape of an anatomical feature and serve as a template for tissue repair or replacement. A method of making an acellular soft tissue-derived matrix includes steps of removing lipid from the soft tissue by solvent extraction and chemical decellularization of the soft tissue.

Claims (28)

1. A method of preparing an adipose tissue-derived matrix, comprising the steps of:

(a) obtaining an adipose tissue;

(b) mechanically reducing the size of the adipose tissue;

(c) delipidating the adipose tissue by contacting the adipose tissue with a polar organic solvent such that lipids are transferred from the adipose tissue to the polar organic solvent, thereby producing a delipidated adipose tissue from which substantially all of the lipids native to the adipose tissue have been removed;

(d) decellularizing the delipidated adipose tissue after step (c), thereby producing a delipidated, decellularized adipose tissue which is essentially free of native cells and cellular components.

2. The method claim 1 , comprising the further step of separating the adipose tissue from lipids released from the adipose tissue during the mechanically reducing step (b).

3. The method of claim 1 , wherein said step of mechanically reducing the size of the adipose tissue includes grinding the adipose tissue with a coarse grinding plate, then grinding the ground adipose tissue with a fine grinding plate.

4. The method of claim 1 , wherein said delipidating step includes washing the adipose tissue with a polar organic solvent, wherein the polar solvent includes a substituted hydrocarbon having a number of carbon atoms in the range of two carbon atoms to six carbon atoms, and said substituted hydrocarbon is selected from the group consisting of a chlorinated hydrocarbon, a fluorinated hydrocarbon, an alcohol, an ether, a ketone, an aldehyde, an ester, an organic acid, and combinations thereof.

5. The method of claim 1 , wherein said delipidating step includes blending the adipose tissue with a polar organic solvent, Wherein the polar solvent includes a substituted hydrocarbon having a number of carbon atoms in the range of two carbon atoms to six carbon atoms, and said substituted hydrocarbon is selected from the group consisting of a chlorinated hydrocarbon, a fluorinated hydrocarbon, an alcohol, an ether, a ketone, an aldehyde, an ester, an organic acid, and combinations thereof.

6. The method of claim 1 , wherein said delipidating step includes homogenizing the adipose tissue with a polar organic solvent, wherein the polar solvent includes a substituted hydrocarbon having a number of carbon atoms in the range of two carbon atoms to six carbon atoms, and said substituted hydrocarbon is selected from the group consisting of a chlorinated hydrocarbon, a fluorinated hydrocarbon, an alcohol, an ether, a ketone, an aldehyde, an ester, an organic acid, and combinations thereof.

7. The method of claim 1 , wherein said decellularizing step includes contacting the delipidated adipose tissue with a detergent solution, wherein said detergent is present in said solution at a concentration in a range of from about 0.1% to about 5.0% (w/v).

8. The method of claim 7 , wherein the detergent solution includes a deoxycholate salt.

9. The method of claim 7 , wherein the detergent solution includes a mixture of water and alcohol.

10. The method of claim 9 , wherein the alcohol is present in the detergent solution in an amount in a range of from about 20% to about 40% by volume.

11. The method of claim 1 , comprising the further step of soaking the delipidated, decellularized adipose tissue in a disinfectant solution.

12. The method of claim 11 , comprising the further step of blending the delipidated, decellularized adipose tissue with the disinfectant solution.

13. The method of claim 11 , wherein the disinfectant solution is an acidic solution that includes peracetic acid.

14. The method of claim 11 , wherein the disinfectant solution includes an alcohol and a glycol.

15. The method of claim 11 , wherein substantially all substances that pose a significant risk of causing an immunogenic response in a patient receiving said adipose tissue-derived matrix are removed from the adipose tissue.

16. The method of claim 11 , wherein substantially all native lipids and native nucleic acids are removed from the adipose tissue.

17. The method of claim 1 , comprising the further step of contacting the delipidated, decellularized adipose tissue with a solution having an acidic pH so as to form a gel.

18. The method of claim 1 , comprising the further step of blending the delipidated, decellularized adipose tissue in a polar liquid, whereby the delipidated, decellularized adipose tissue and the polar liquid form a flowable gel.

19. The method of claim 1 , comprising the further steps of drying the delipidated, decellularized adipose tissue, and reducing the dried delipidated, decellularized adipose tissue to a dried particulate form.

20. The method of claim 8 , wherein the detergent solution includes a mixture of water and alcohol.

21. The method of claim 12 , wherein the disinfectant solution is an acidic solution that includes peracetic acid.

22. The method of claim 12 wherein the disinfectant solution includes an alcohol and a glycol.

23. The method of claim 12 , wherein substantially all substances that pose a significant risk of causing an immunogenic response in a patient receiving said adipose tissue-derived matrix are removed from the adipose tissue.

24. The method of claim 12 , wherein substantially all native lipids and native nucleic adds are removed from the adipose tissue.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2025
From: HUANG, YEN-CHEN; IVERY, ASIA; CHOI, BRYAN; SCHILLING, BENJAMIN; NGO, MANH-DAN
To: MUSCULOSKELETAL TRANSPLANT FOUNDATION
Reel/Frame 072097/0352 →
SECURITY INTEREST Recorded Jul 27, 2023
From: MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.
To: M&T BANK
Reel/Frame 064401/0369 →
SECURITY INTEREST Recorded Dec 23, 2020
From: MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.
To: M&T BANK
Reel/Frame 054842/0458 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2018
From: HUANG, YEN-CHEN; IVERY, ASIA; CHOI, BRYAN; SCHILLING, BENJAMIN; NGO, MANH-DAN
To: MUSCULOSKELETAL TRANSPLANT FOUNDATION
Reel/Frame 046318/0519 →
Continuity (3)
Division 14446629 · Jul 30, 2014
Provisional Application 61860043 · Jul 30, 2013
Related Publication 20170119826A1 · May 4, 2017
Cited By (2)
US 12,447,180 US 12,629,453